Q2FY26 EARNING CALENDAR: ACC, APTUS, AWHCL, BAJAJELEC, BALKRISIND, BANKBARODA, BEL, BFUTILITIE, BPCL, DHANUKA, EQUITASBNK, GAIL, GODREJCP, HEUBACHIND, IFBAGRO, INTELLECT, JUBLPHARMA
AHMEDABAD, 31 OCTOBER:
| 31.10.2025: | ACC, APTUS, AWHCL, BAJAJELEC, BALKRISIND, BANKBARODA, BEL, BFUTILITIE, BPCL, DHANUKA, EQUITASBNK, GAIL, GODREJCP, HEUBACHIND, IFBAGRO, INTELLECT, JUBLPHARMA, KPIL, LALPATHLAB, LGBBROSLTD, MAHLIFE, MARUTI, MEDPLUS, MHRIL, NOCIL, NORTHARC, PATANJALI, PHOENIXLTD, PRSMJOHNSN, RRKABEL, RTNPOWER, SAMMAANCAP, SCHAEFFLER, SEKURITIND, SHRIRAMFIN, SPANDANA, STAR, STEELCAS, TATVA, VEDL, ZENSARTECH | 
BANKBARODA YoY
• NII expected at Rs 11185 crore versus Rs 11622 crore
• EBIT expected to be seen at Rs 7596 crore versus Rs 9477 crore
• EBIT margin expected to be seen at 49.37% versus 56.40%
• Net profit expected to be seen at Rs 4348 crore versus Rs 5237 crore
BEL YoY
• Revenue expected at Rs 5572 crore versus Rs 4604 crore
• EBITDA expected to be seen at Rs 1440 crore versus Rs 1400 crore
• EBITDA margin expected to be seen at 25.85% versus 30.40%
• Net profit expected to be seen at Rs 1007 crore versus Rs 1092 crore
BPCL QoQ
• Revenue expected at Rs 108521 crore versus Rs 112551 crore
• EBITDA expected to be seen at Rs 9454 crore versus Rs 9678 crore
• EBITDA margin expected to be seen at 8.71% versus 8.59%
• Net Profit expected to be seen at Rs 5750 crore versus Rs 6906 crore
GAIL QoQ
• Revenue expected at Rs 36168 crore versus Rs 34792 crore
• EBITDA expected to be seen at Rs 3287 crore versus Rs 3333 crore
• EBITDA margin expected to be seen at 9.08% versus 9.58%
• Net Profit expected to be seen at Rs 2202 crore versus Rs 1886 crore
GODREJCP YoY
• Revenue expected at Rs 3893 crore versus Rs 3666 crore
• EBITDA expected to be seen at Rs 740 crore versus Rs 759 crore
• EBITDA margin expected to be seen at 19.01% versus 20.72%
• Net profit expected to be seen at Rs 506 crore versus Rs 497 crore
MARUTI YoY
• Revenue expected at Rs 39531 crore versus Rs 37202 crore
• EBITDA expected to be seen at Rs 3674 crore versus Rs 4416 crore
• EBITDA margin expected to be seen at 9.29% versus 11.87%
• Net profit expected to be seen at Rs 3564 crore versus Rs 3069 crore
PATANJALI YoY
• Revenue expected at Rs 9387 crore versus Rs 8154 crore
• EBITDA expected to be seen at Rs 498 crore versus Rs 449 crore
• EBITDA margin expected to be seen at 5.31% versus 5.50%
• Net profit expected to be seen at Rs 334 crore versus Rs 308 crore
VEDL YoY
• Revenue expected at Rs 38258 crore versus Rs 37171 crore
• EBITDA expected to be seen at Rs 11356 crore versus Rs 9828 crore
• EBITDA margin expected to be seen at 29.68% versus 26.44%
• Net profit expected to be seen at Rs 3846 crore versus Rs 1752 crore
| 01.11.2025: | AFFLE, AZAD, DOLPHIN, GHCL, GNA, INDRAMEDCO, JKCEMENT, NETWEB, ORIENTCEM, SALZERELEC, SANGHIIND, SBFC, TAJGVK, TATACHEM | 
JKCEMENT YoY
• Revenue expected at Rs 2795 crore versus Rs 2560 crore
• EBITDA expected to be seen at Rs 469 crore versus Rs 284 crore
• EBITDA margin expected to be seen at 16.79% versus 11.09%
• Net profit expected to be seen at Rs 183 crore versus Rs 23 crore
TATACHEM YoY
• Revenue expected at Rs 4103 crore versus Rs 3999 crore
• EBITDA expected to be seen at Rs 670 crore versus Rs 618 crore
• EBITDA margin expected to be seen at 16.35% versus 15.45%
• Net profit expected to be seen at Rs 232 crore versus Rs 194 crore
| 03.11.2025: | 3MINDIA, ACMESOLAR, AJANTPHARM, AMBUJACEM, ARVINDFASN, ARVSMART, AURIONPRO, AWL, BHARTIARTL, BHARTIHEXA, CANTABIL, CUB, DODLA, DPABHUSHAN, GALLANTT, GHVINFRA, GLAND, GODFRYPHLP, GVTD, IGPL, INDPRUD, JAGSNPHARM, JKPAPER, KANSAINER, KIRLOSBROS, MAHSCOOTER, MAXESTATES, NIVABUPA, POWERGRID, POWERINDIA, PUNJABCHEM, ROUTE, SJS, STOVEKRAFT, TATACONSUM, TBOTEK, THANGAMAYL, TIMKEN, TITAN, VIMTALABS, VINCOFE, VRLLOG, WEBELSOLAR, WESTLIFE, WOCKPHARMA | 
AMBUJACEM YoY
• Revenue expected at Rs 9039 crore versus Rs 7516 crore
• EBITDA expected to be seen at Rs 1509 crore versus Rs 1111 crore
• EBITDA margin expected to be seen at 16.69% versus 14.79%
• Net profit expected to be seen at Rs 589 crore versus Rs 612 crore
BHARTIARTL YoY
• Revenue expected at Rs 50703 crore versus Rs 41473 crore
• EBITDA expected to be seen at Rs 28122 crore versus Rs 21846 crore
• EBITDA margin expected to be seen at 55.47% versus 52.68%
• Net profit expected to be seen at Rs 6681 crore versus Rs 4446 crore
BHARTIHEXA YoY
• Revenue expected at Rs 2331 crore versus Rs 2097 crore
• EBITDA expected to be seen at Rs 1239 crore versus Rs 1001 crore
• EBITDA margin expected to be seen at 53.15% versus 47.76%
• Net profit expected to be seen at Rs 457 crore versus Rs 253 crore
GVTD YoY
• Revenue expected at Rs 1440 crore versus Rs 1107 crore
• EBITDA expected to be seen at Rs 288 crore versus Rs 204 crore
• EBITDA margin expected to be seen at 20.00% versus 18.48%
• Net profit expected to be seen at Rs 213 crore versus Rs 144 crore
POWERGRID YoY
• Revenue expected at Rs 11771 crore versus Rs 11277 crore
• EBITDA expected to be seen at Rs 9834 crore versus Rs 9701 crore
• EBITDA margin expected to be seen at 83.55% versus 86.02%
• Net profit expected to be seen at Rs 4009 crore versus Rs 3793 crore
POWERINDIA YoY
• Revenue expected at Rs 2063 crore versus Rs 1553 crore
• EBITDA expected to be seen at Rs 242 crore versus Rs 109 crore
• EBITDA margin expected to be seen at 11.74% versus 7.06%
• Net profit expected to be seen at Rs 177 crore versus Rs 52 crore
TATACONSUM YoY
• Revenue expected at Rs 4735 crore versus Rs 4214 crore
• EBITDA expected to be seen at Rs 627 crore versus Rs 626 crore
• EBITDA margin expected to be seen at 13.24% versus 14.86%
• Net profit expected to be seen at Rs 368 crore versus Rs 391 crore
TITAN YoY
• Revenue expected at Rs 16255 crore versus Rs 14534 crore
• EBITDA expected to be seen at Rs 1619 crore versus Rs 1236 crore
• EBITDA margin expected to be seen at 9.96% versus 8.50%
• Net profit expected to be seen at Rs 1028 crore versus Rs 704 crore
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)

 
                         
                         
                         
             
			                             
			                            